SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Covalent Group Inc (CVGR) an undiscovered CRO

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vampire who wrote (64)11/9/1998 11:06:00 AM
From: JanyBlueEyes   of 107
 
NEWS - $13.6 MILLION STUDY

Covalent Group, Inc. to Conduct $13.6 Million Clinical Development Study

WAYNE, Pa., Nov. 9 /PRNewswire/ -- Covalent Group, Inc. (NASDAQ:CVGR) today announced receiving the award of a $13.6 million contract from a leading pharmaceutical firm to conduct a major, multi-year, clinical development study. The contract also provides for Covalent to administer and manage an additional $25 million in investigator grants, clinical development fees, and other related expenses.

Bruce LaMont, President and Chief Executive Officer commented, "We are extremely pleased to have been selected by a world class organization to manage a study which is of great importance to the success of our client's drug in the marketplace." Mr. LaMont added, "This new study of a flagship product in a major therapeutic area interfaces with our core competency in advanced clinical research, and continues to demonstrate our company's experience and expertise in providing innovative solutions to meet clients' needs."

Covalent provides drug development and health management solutions to pharmaceutical and device manufacturers, as well as managed care organizations. To aid its pharmaceutical and managed care customers, Covalent has developed a disease assessment system using interactive voice recognition technology -- Virtual HouseCall.

This press release contains forward-looking statements........

Contact Covalent on-line: cracorp.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext